ArticleBiomedical optics express2025
Development of a multispectral imaging apparatus for cost-effective fundus disease detection.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comprehensive and Region-Specific Retinal Health Assessment Using Phasor Analysis of Multispectral Images and Machine Learning.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fundus spectral imaging (FSI) integrates fundus photography with spectral techniques, providing both spatial and spectral information for retinal imaging. Whereas existing FSI systems have demonstrated advantages in structural and functional imaging, their widespread adoption is hindered by high costs and complex optical designs. To address these challenges, we propose a low-cost multispectral fundus camera with a simplified optical design, built from off-the-shelf optics, 3D-printed parts, and equipped with fiber-bundle-coupled multi-wavelength LED illumination source (470-740 nm). Additionally, the proposed multispectral imaging apparatus incorporates a coaxial non-separated polarization-based reflection suppression technique, using orthogonal polarizers to suppress corneal reflections without pupil-plane separation. To the best of our knowledge, this is the first application of such an architecture in the context of FSI. Experimental results demonstrate that the developed system achieves high-quality FSI under low-cost conditions, validating its feasibility as a practical solution. Clinical validation validates its diagnostic capability for diabetic retinopathy, choroidal pigmented nevus, and, notably, the first reported spectral imaging of peripapillary atrophy. The system achieves performance comparable to conventional color fundus photography while enabling superior diagnosis of deep fundus conditions such as choroidal lesions, offering a cost-effective and practical FSI solution for broader deployment in resource-limited settings.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.